The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

Shares of Mankind Pharma Ltd were trading in the red today even as the pharma firm said its board has approved the closure of the issue for the qualified institutions placement (QIP) of equity ...

Despite a year-on-year decline in profit and some margin contraction in the March quarter (Q4FY25), Mankind Pharma is sticking with its conservative margin guidance for FY26. In an interview with CNBC ...

Mankind Pharma slipped 3.51% to Rs 2,444.25 after the company's consolidated net profit declined 10.71% to Rs 420.77 crore in Q4 FY25 as against Rs 471.24 crore posted in Q4 FY24. However, revenue ...

Shares of Mankind Pharma dropped over 3 per cent on Thursday as the company reported a 10 per cent fall in consolidated net profit for the March quarter of 2024-25 (Q4 FY25). The Delhi-based pharma ...

- Per. of shares (as a % of the total sh. of prom. and promoter group)----- - Per. of shares (as a % of the total Share Cap. of the company)----- Advisory Alert: It has come to our attention ...

On Thursday, JPMorgan (NYSE: JPM) analysts revised the price target for Mankind Pharma Ltd (MANKIND:IN), reducing it to INR2,900 from the previous INR3,150.Despite this adjustment, the firm retains an ...

On Thursday, BofA Securities analysts adjusted their outlook on Mankind Pharma Ltd (MANKIND:IN), lowering the price target to INR2,150 from INR2,250, while maintaining an Underperform rating on the ...